RUNX1 is actually a grasp transcription factor that regulates the expression of numerous genes necessary for hematopoiesis. Studies implied that the RUNX1 - "Our study revealed the essential part from the KLF16/MYC regulatory axis in modulating tumor progress and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, such as https://heinzt009juf3.mybuzzblog.com/profile